Skip to main content
ECS BOTANICS HOLDINGS LTD logo

ECS BOTANICS HOLDINGS LTD — Investor Relations & Filings

Ticker · ECS ISIN · AU0000052490 LEI · 254900F6I1ORKXFIGD77 ASX Agriculture, forestry and fishing
Open in API
Filings indexed 913 across all filing types
Latest filing 2019-08-29 Annual Report
Country AU Australia
Listing ASX ECS

About ECS BOTANICS HOLDINGS LTD

https://ecs-botanics.com/

ECS Botanics Holdings Ltd specializes in the large-scale cultivation and manufacture of medicinal cannabis products. The company utilizes organic and sustainable farming practices, including regenerative agriculture, to produce high-quality cannabis flower and oils. Its operations integrate advanced greenhouse technology with outdoor cultivation to ensure cost-effective production. The product portfolio includes a range of pharmaceutical-grade dried flowers and extracted oils tailored for medical applications. Serving both domestic and international markets, the company focuses on supplying GMP-compliant products to healthcare providers and pharmaceutical distributors. By leveraging low-cost production models and environmentally conscious methodologies, the organization maintains a competitive position in the global medicinal supply chain.

Recent filings

Filing Released Lang Actions
Appendix 4E & Annual Report to shareholders 38 pages 577.8KB
Annual Report Classification · 100% confidence The document is titled 'ASX APPENDIX 4E' and is for ECS Botanics Holdings Limited for the year ended 30 June 2019. It includes detailed financial information such as revenue, net loss, dividends, net tangible assets per security, earnings per share, and a comprehensive table of contents listing sections typical of an annual report: Directors' Report, Auditor's Independence Declaration, Financial Statements, Notes to Financial Statements, Directors' Declaration, Independent Auditor's Report, Corporate Governance Statement, and ASX Additional Information. The document also contains detailed information about the board of directors, company secretary, principal activities, and a review of operations. The length of the document is substantial (15,000 characters), indicating it is the full report rather than a brief announcement. The presence of audited financial statements and the comprehensive nature of the content confirm this is the official yearly report covering company activity and full financial performance. Therefore, the document fits the definition of an Annual Report (10-K). FY 2019
2019-08-29 English
Appendix 4G & Corporate Governance Statement 21 pages 317.4KB
Governance Information Classification · 95% confidence The document is titled 'Appendix 4G' and references ASX Listing Rules 4.7.3 and 4.10.3, which relate to corporate governance disclosures that must accompany the annual report. It contains detailed disclosures about the company's adherence to the ASX Corporate Governance Council Principles and Recommendations for the financial year ended 30 June 2019. The document is a corporate governance statement approved by the board and lodged with the ASX alongside the annual report. It is not the annual report itself but a governance disclosure document required by listing rules. This fits the definition of Governance Information (CGR), which covers reports detailing the company's internal rules, board structure, and governance practices. The document is substantive (15,000 characters) and contains detailed governance disclosures, not just an announcement or a brief note. Therefore, the correct classification is CGR with high confidence.
2019-08-29 English
Response to ASX Query 5 pages 378.3KB
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from ECS Botanics Holdings Limited to the Australian Securities Exchange (ASX) regarding a query about the timing and disclosure of negotiations and a strategic investment. It references specific ASX Listing Rules (3.1, 3.1A), the Corporations Act 2001, and continuous disclosure obligations. The content is focused on compliance with regulatory disclosure requirements and clarifies the company's position on whether a supplementary prospectus was necessary. There are no financial statements, earnings data, or management discussion of financial results. The document is a regulatory compliance communication responding to an ASX query, not a financial report or announcement of financial results. It fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-08-20 English
Response to ASX Aware Query 8 pages 386.7KB
Regulatory Filings Classification · 95% confidence The document is a detailed response letter from ECS Botanics Holdings Ltd to the Australian Securities Exchange (ASX) regarding a query about a strategic investment in TapAgrico. It discusses the timing of the investment agreement, disclosure obligations under ASX Listing Rules, funding details, and compliance with continuous disclosure policies. The content is regulatory in nature, addressing compliance and disclosure questions rather than presenting financial results, management changes, or other report types. It is not an annual report, earnings release, or financial statement. It is also not a short announcement but a detailed regulatory response letter. Therefore, it fits best under Regulatory Filings (RNS), which covers general regulatory announcements and compliance documents that do not fit other categories.
2019-08-14 English
Strategic investment in TapAgrico & Distribution Agreement 2 pages 177.2KB
Capital/Financing Update Classification · 95% confidence The document is an ASX announcement dated 13 August 2019 regarding ECS Botanics Holdings Ltd securing a strategic investment in TapAgrico and signing a distribution agreement with Eden Foods. The content focuses on investment details, shareholding percentage, and a new distribution agreement. There are no financial statements, quarterly or annual results, nor any regulatory certifications or voting results. The document is a corporate announcement about financing and strategic partnership activities. Therefore, it fits best under Capital/Financing Update (CAP) as it relates to investment and capital structure changes.
2019-08-12 English
ECS Botanics Holding Ltd begins trading on ASX 2 pages 133.5KB
Capital/Financing Update Classification · 95% confidence The document is an ASX release dated 22 July 2019 announcing that ECS Botanics Holdings Ltd has commenced trading on the ASX following an oversubscribed $6.5 million capital raise. The text focuses on the capital raising event, the company's business focus, and future plans. There are no financial statements or detailed financial performance data included. The document is relatively short (3043 characters) and serves as an announcement of a financing event and the start of trading under a new code. This fits the definition of a Capital/Financing Update (CAP) rather than a full financial report or other categories.
2019-07-21 English

Browse filings by year

24 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.